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Abstract 26 
Objective: The brain plays a prominent role in the regulation of inflammation. Immune cells are 27 
under control of the so-called cholinergic anti-inflammatory reflex, mainly acting via autonomic 28 
innervation of the spleen. Activation of this reflex inhibits the secretion of pro-inflammatory 29 
cytokines and may reduce the development of atherosclerosis. Therefore, the aim of this study 30 
was to evaluate the effects of selective parasympathetic (Px) and sympathetic (Sx) denervation 31 
of the spleen on inflammatory status and atherosclerotic lesion development. 32 
Methods & Results: Female APOE*3-Leiden.CETP mice, a well-established model for human-33 
like lipid metabolism and atherosclerosis, were fed a cholesterol-containing Western-type diet  34 
for 4 weeks after which they were sub-divided into three groups receiving either splenic Px, 35 
splenic Sx or sham surgery. The mice were subsequently challenged with the same diet for an 36 
additional 15 weeks. Selective Px increased leukocyte counts (i.e. dendritic cells, B cells and T 37 
cells) in the spleen and increased gene expression of pro-inflammatory cytokines in the liver and 38 
peritoneal leukocytes as compared to Sx and sham surgery. Both Px and Sx increased 39 
circulating pro-inflammatory cytokines IL-1β and IL-6. However, the increased pro-inflammatory 40 
status in denervated mice did not affect atherosclerotic lesion size or lesion composition. 41 
Conclusion: Predominantly selective Px of the spleen enhances the inflammatory status, which 42 
however does not aggravate diet-induced atherosclerotic lesion development. 43 
 44 
New & Noteworthy statement 45 
Splenic immune cells are involved atherosclerosis development and their inflammatory status is 46 
controlled by the anti-inflammatory reflex. Here we show that both selective sympathetic and 47 
parasympathetic denervation of the spleen results in enhanced pro-inflammatory cytokine 48 
production, but does not aggravate atherosclerosis development. 49 
50 
3 
 
Introduction 51 
Atherosclerosis is a chronic inflammatory disease initiated by innate and adaptive immune 52 
responses to endogenously modified structures, in particular oxidized lipoproteins, within the 53 
arterial wall (8). The autonomic nervous system may enhance innate immune responses by 54 
sympathetic activity (reviewed in 12), while it suppresses inflammation via the vagus nerve, a 55 
mechanism termed the cholinergic anti-inflammatory pathway (3; 7). In response to circulating 56 
pro-inflammatory cytokines afferent vagal nerves are directly activated. Subsequent efferent 57 
vagal activity results in the release of acetylcholine which activates the α7 nicotinic acetylcholine 58 
receptor (α7nAChR) on resident tissue macrophages and other immune cells, thereby inhibiting 59 
the production and release of pro-inflammatory cytokines (e.g. TNFα, IL-6, IL-1β) (24). α7nAChR 60 
is integral to the cholinergic anti-inflammatory pathway, as vagus nerve stimulation fails to inhibit 61 
TNFα production in pharmacologically α7nAChR inhibited or α7nAChR-deficient mice (18; 24). 62 
Recently, we demonstrated that hematopoietic α7nAChR deficiency in dyslipidemic mice 63 
enhances systemic inflammation as evidenced by increased leukocytes in the blood, lymph 64 
nodes, spleen and peritoneum (all by at least 2-fold) and increased gene expression of TNFα in 65 
peritoneal leukocytes and spleen (15). 66 
As the spleen contains half of the body’s monocyte population, it is not surprising that the 67 
cholinergic anti-inflammatory pathway acts mainly via the spleen. Indeed, Huston et al. (11) 68 
reported that vagus nerve stimulation fails to inhibit TNFα production in splenectomised animals 69 
during endotoxemia, indicating an essential role for the spleen in the cholinergic anti-70 
inflammatory pathway. Furthermore, splenectomy reduces the production of antibodies directed 71 
against oxidized LDL in apoE-deficient mice and was associated with increased atherosclerotic 72 
lesion development (16). Trauma patients who undergo splenic removal are more prone to 73 
develop coronary heart disease, in which enhanced atherosclerotic lesion development may be 74 
causal (17). 75 
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Taken together, these findings suggests that autonomic innervation of the spleen and the 76 
development of atherosclerosis may be closely interrelated. Therefore, the aim of this study was 77 
to determine the effect of selective parasympathetic denervation (Px), as compared to 78 
sympathetic denervation (Sx) of the spleen and sham surgery, on systemic inflammation and 79 
atherosclerotic lesion development in female APOE*3-Leiden.CETP mice, a well-established 80 
mouse model for human-like lipoporotein metabolism. 81 
82 
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Material and Methods 83 
 84 
Animals 85 
APOE*3-Leiden mice were crossbred with mice expressing human cholesteryl ester transfer 86 
protein (CETP) under control of its natural flanking regions to generate heterozygous APOE*3-87 
Leiden.CETP mice (25). Mice were housed under standard conditions with a 12:12h light:dark 88 
cycle and had free access to food and water. At the age of 10-12 weeks, female APOE*3-89 
Leiden.CETP mice received a Western-type diet (WTD) containing 0.1% cholesterol (w/w), 1% 90 
(w/) corn oil and 15% (w/w) cacao butter (AB diets, Woerden, the Netherlands). After a run-in 91 
period of 4 weeks, mice (n=45) were randomized based on plasma lipid levels and body weight 92 
into three groups (n=15 each) receiving either splenic parasympathetic denervation (Px), splenic 93 
sympathetic denervation (Sx) or sham surgery. A schematic representation of the innervation of 94 
the spleen and the sites of denervation can be found in Fig. 1A. For all surgeries, mice were 95 
anesthetized by an intraperitoneal (i.p.) injection of a mixture of fentanylcitrate/ﬂuanisone 96 
(Hypnorm; Janssen, Beerse, Belgium), midazolam (Dormicum; Roche, Mijdrecht, The 97 
Netherlands), and H2O (1: 1: 2, v/v). All animal experiments had been approved by the 98 
Institutional Ethics Committee on Animal Care and Experimentation. 99 
 100 
Selective parasympathetic denervation of the spleen 101 
Since parasympathetic nerves enter the spleen at both tips, these tips were sequentially 102 
exposed during surgery to allow cutting of the nerves. After a midline abdominal incision the 103 
spleen was pulled gently towards the site of the incision, and the nerve at the tip of the spleen 104 
was cut. The connective tissue between the tip and the first hilus was also removed, as some 105 
parasympathetic input reaches the spleen via this connective tissue. Subsequently, the spleen 106 
was further pulled towards the midline to reach the lower tip of the spleen. After following back 107 
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the nerve to the plexus, the connective tissue from this plexus back to the spleen was removed. 108 
The wound was closed with novosyn suture (B. Braun Medical, Oss, The Netherlands) (5). 109 
 110 
Selective sympathetic denervation of the spleen 111 
A midline abdominal incision was performed along the linea alba and the stomach was pushed 112 
up and to the right to reveal the blood vessels to and from the spleen. After the arterial branch to 113 
the stomach a bifurcation indicates the first branching point of the arterial supply to the spleen. 114 
From this bifurcation on the arteries will split many times and end at the hili of the spleen. 115 
Sympathetic nerves run along and around these arteries to reach the spleen. The area just 116 
before and after the bifurcation was chosen to remove the sympathetic nerves. The wound was 117 
closed with novosyn suture (B. Braun Medical, Oss, The Netherlands) (5). Sympathetic 118 
denervation was confirmed 15 weeks after surgery by Western blotting for tyrosine hydroxylase 119 
(TH; anti-TH antibody; AB-112; Abcam). 120 
 121 
Gene expression analysis in spleen, liver and peritoneal leukocytes 122 
After surgery, the mice were fed the WTD for another 15 weeks. Subsequently, mice were 123 
sacrificed and organs were collected and peritoneal leukocytes isolated by lavage of the 124 
peritoneum with ice-cold PBS. Total RNA from spleen, liver and peritoneal leukocytes was 125 
isolated using the Nucleospin RNA II kit (Macherey-Nagel, Düren, Germany) according to 126 
manufacturer's instructions. One microgram of total RNA was converted to cDNA with iScript 127 
cDNA Synthesis kit (Biorad) and purified with Nucleospin Extract II kit (Macherey-Nagel). Real-128 
time polymerase chain reaction (RT-PCR) was conducted on the IQ5 PCR machine (Biorad) 129 
using the Sensimix SYBR Green RT-PCR mix (Quantace, London, UK). mRNA levels were 130 
normalized to mRNA levels of β2 microglobulin, cyclophilin, and acidic ribosomal 131 
phosphoprotein P0 (36B4). 132 
 133 
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Flow cytometry analysis 134 
From five randomly selected animals per group, peripheral blood and spleens were processed 135 
for flow cytometry. Thereto, single cell suspensions were obtained by mashing the cells trough a 136 
70 µm cell strainer (Falcon, The Netherlands). Subsequently, cells were counted and 2x106 cells 137 
were stained with appropriate antibodies (Table 1) to determine immune cell subsets: Live 138 
immune cells were selected from the forward and sideward scatter, and populations of B cells 139 
(CD19+), dendritic cells (CD11c+CD14-), T cells (CD3+), neutrophils (CD11b+Ly6Ghigh) , and 140 
macrophages (CD14+CD11b+) were identified. Specific T cell subsets were determined within 141 
the CD3+ fraction as T helper cells (CD4+), cytotoxic T cells (CD8+), activated T cells (CD25+), 142 
naïve T cells (CD62L+). Data were acquired on a FACSAria or a FACSCanto II (BD 143 
Biosciences). Analyses were performed using FlowJo software (Treestar, Ashland, OR, USA). 144 
Gating strategy is shown in Fig. 1B. 145 
 146 
Serum measurements 147 
Serum was isolated and stored frozen at -80°C until further analyses. The cytokines TNFα, IL-1β 148 
and IL-6 were determined using V-PLEX Proinflammatory Panel1 (mouse) Kit (Meso Scale 149 
Discovery, Rockville, ML, USA) according to the manufacturer’s instructions. In 50x diluted 150 
serum samples, E-selectin concentrations were measured according to the manufacturer’s 151 
instructions (DY575, R&D systems, Minneapolis, MN, USA). 152 
 153 
Plasma lipid and lipoprotein analyses 154 
Blood was collected after a 4-h fast into EDTA-containing cups by tail bleeding, and plasma was 155 
isolated by centrifugation and stored frozen at -80°C until further analyses. The concentrations 156 
of total cholesterol (TC) and triglycerides (TG) in plasma were determined using commercially 157 
available enzymatic colorimetric kits according to the manufacturer’s protocols (236691 and 158 
1488872; Roche Molecular Biochemicals, Indianapolis, IN, USA). The concentrations of 159 
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phospholipids (PL) in plasma were determined using a commercially available enzymatic 160 
colorimetric kit (3009; Instruchemie, Delfzijl, The Netherlands). The distribution of lipids over the 161 
different lipoproteins in plasma was determined after fractionation of pooled plasma (14-15 mice 162 
per pool) by FPLC using a Superose 6 HR 10/30 column (Äkta System; Amersham Pharmacia 163 
Biotech, Piscataway, NJ). 164 
 165 
Atherosclerosis quantification 166 
From all mice, hearts were isolated and fixed in phosphate-buffered 4% formaldehyde, 167 
dehydrated and embedded in paraffin. Cross-sections (5 μm) were made throughout the aortic 168 
root area and stained with hematoxylin-phloxine-saffron for histological analysis. Lesions were 169 
categorized for severity according to the guidelines of the American Heart Association adapted 170 
for mice (27). Various types of lesions were discerned: no lesions, mild lesions (types 1-3) and 171 
severe lesions (types 4-5). Immunohistochemistry for determination of lesion composition was 172 
performed as described previously (10). Rat anti-mouse antibody MAC3 (1:1000; BD 173 
Pharmingen, Breda, The Netherlands) was used to quantify macrophage area. Monoclonal 174 
mouse antibody M0851 (1:800; Dako, Heverlee, the Netherlands) against smooth muscle cell 175 
(SMC) α-actin was used to quantify SMC area. Sirius Red was used to quantify collagen area. 176 
Lesion area was quantified in the aortic root starting from the appearance of open aortic valve 177 
leaflets in four subsequent sections with 50 μm intervals. In ImageJ the lesions were delineated 178 
to determine mean lesion area (in µm2) and a color threshold was set to determine the area 179 
percentage of MAC3, SMC or collagen staining in a consistent manner across the different 180 
slides. 181 
 182 
Statistical analysis 183 
Data are presented as means ± SEM unless indicated otherwise. To compare differences 184 
among groups one-way ANOVA with Turkey’s post-test was performed using GraphPad Prism 185 
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version 4.00 for Windows (GraphPad Software, San Diego, CA, USA, www.graphpad.com). 186 
Differences at a P-value <0.05 were considered statistically significant. 187 
188 
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Results 189 
Female APOE*3-Leiden.CETP mice were fed a WTD during 4 weeks, and were randomized into 190 
three groups receiving either parasympathetic denervation (Px) of the spleen, sympathetic 191 
denervation (Sx) of the spleen (Fig. 1A), or sham surgery. After surgery, the mice received WTD 192 
feeding for 15 additional weeks to induce atherosclerotic lesion development. To confirm that Sx 193 
was successful and that sympathetic nerves did not regenerate, tyrosine hydroxylase (TH) 194 
content of the spleen was determined (Fig. 1C), showing the absence of TH still 15 weeks after 195 
Sx. Upon sacrification of the mice, the tips of the spleen were gently exposed to confirm that the 196 
re-innervation of the parasympathetic nerves was not the case. 197 
 198 
Splenic parasympathetic denervation increases immune cell count in spleen 199 
The spleen plays an important role in the immune system and, therefore, contains a wide range 200 
of immune cell types, including monocytes, macrophages, dendritic cells, neutrophils, T cells 201 
and B cells. To define the effect of the selective denervations on immune cell composition, flow 202 
cytometry analyses were performed. Total splenic immune cell count was increased (+49%, 203 
p<0.01) in Px mice (200±10 x106 cells) compared to sham operated mice (134±10 x106 cells), 204 
while Sx denervation did not affect immune cell count (156±25 x106 cells) (Fig. 2A). In a fraction 205 
of immune cells (i.e. 2.0x106 cells), percentages of each cell type were analyzed using flow 206 
cytometry and multiplied with total immune cell counts (see Fig. 1B for the gating strategy). This 207 
revealed an increase in the number of various immune cell subtypes, including B cells (98±7 208 
x106 cells vs. 61±5 x106 cells, p<0.01) (Fig. 2B), T cells (63±4 x106 cells vs. 41±4 x106 cells, 209 
p<0.01) (Fig. 2C) and dendritic cells (DCs; 10±1 x106 cells vs. 7±1 x106 cells, p<0.05) (Fig. 2D). 210 
Neutrophils (Fig. 2E) and monocytes/macrophages (Fig. 2F) only showed a non-significant 211 
increase upon Px. 212 
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As T cells are probably involved in the propagation of nerve signals towards monocytes 213 
and macrophages (19), the phenotype of the T cells (i.e naivity or activation status of the T 214 
helper or cytotoxic T cells) was further studied. In accordance to the general increase in various 215 
immune cells, Px increased both T-helper (TH; +60%, p<0.01) (Fig. 2G) and cytotoxic T cells 216 
(Tcyt; +49%, p<0.01) (Fig. 2H). Further subdivision revealed that Px increased naïve (Fig. 2I) as 217 
well as activated (Fig. 2J) TH cells, and increased naïve Tcyt cells (Fig. 2K) without increasing 218 
activated Tcyt cells (Fig. 2L). Thus, splenic Px resulted in an overall increase in immune cells in 219 
the spleen, while Sx did not affect immune cell count compared to sham surgery, indicating the 220 
importance of the parasympathetic nerve in regulation of the immune system. 221 
 222 
Splenic autonomic denervation increases expression of inflammatory cytokines 223 
During the course of the experiment, body weight gain was slightly lower in both Px and Sx 224 
mice. At the end of the experiment, body weight of sham operated mice was 31.6 ±1.1 g, 225 
compared to 27.3 ±1.1 g (p<0.05) and 27.4 ±1.2 g (p<0.05) for Px and Sx mice, respectively 226 
(Fig. 3A). Splenic weight tended to be increased in Px (Fig. 3B) and was different when 227 
expressed as percentage of the body weight for Px (0.52 ±0.02 %; p<0.001) and Sx (0.47 ±0.02 228 
%; p<0.05) compared to sham (0.41 ±0.01 %) (Fig. 3C). Gene expression analyses revealed 229 
that Px only caused a trend towards an increase of the inflammatory cytokines IL-1β and IL-6 230 
within the spleen (Fig. 3D). Further analysis of other organs showed no difference in liver weight 231 
when expressed as percentage of the body weight (Fig. 3E). Interestingly, Px increased gene 232 
expression of IL-6 in the liver (+80%; p<0.01) (Fig. 3F) and increased gene expression of TNFα, 233 
IL-1β and IL-6 in isolated peritoneal leukocytes, which reached significance for IL-1β (3.3-fold; 234 
p<0.05) (Fig. 3G). Next we determined the effect of Px on white blood cell count in peripheral 235 
blood and further analysed subsets by flow cytometry. Px tended to increase total immune cell 236 
count albeit significance was not reached (+41%; p=0.18) (Fig. 4A). Subdivision of leukocytes 237 
into B cells (Fig. 4B), T cells (Fig. 4C), dendritic cells (Fig. 4D), neutrophils (Fig. 4E) or 238 
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monocytes (Fig. 4F) did not reveal differences. However, as the number of immune cells per se 239 
does not reflect activity of these cells, we measured serum levels of TNFα (Fig. 4G), IL-1β (Fig. 240 
4H) and IL-6 (Fig. 4I) in serum. While TNFα levels remained unaffected, both IL-1β and IL-6 241 
serum concentrations were increased by Px. Interestingly, in contrast to our gene expression in 242 
liver, spleen and peritoneal leukocytes, also Sx increased inflammatory status as IL-1β and IL-6 243 
levels compared to sham operated mice. 244 
 245 
Splenic autonomic denervation does not affect atherosclerotic lesion development 246 
Since inflammation can influence lipid metabolism (22), we next evaluated whether selective 247 
splenic denervations had an effect on lipid metabolism. Plasma total cholesterol (TC), 248 
phospholipids (PL) and triglycerides (TG) were assessed at 2, 4, 6 and 15 weeks after surgery. 249 
No differences in plasma lipid concentrations were found between the Px, Sx and sham 250 
operated mice at weeks 2, 4, 6 (not shown) and 15 weeks (Fig. 4J). Likewise, the distribution of 251 
cholesterol over the various lipoproteins did not differ between Px, Sx or sham control mice (Fig. 252 
4K). Serum E-selectin as marker for vascular inflammation, was increased in Px as well as in Sx 253 
compared to sham, suggesting that immune cell infiltration into atherosclerotic lesions might be 254 
enhanced by the selective denervations (Fig 4L). 255 
To study the effect of splenic denervation on atherosclerosis development, mice were 256 
sacrificed after 15 weeks after surgery, and atherosclerotic lesion size and lesion severity were 257 
determined in the valve area of the aortic root. Both Px and Sx did neither affect atherosclerotic 258 
lesion size (Fig. 5A and 5B) nor lesion severity, when classified as mild (type 1-3) and severe 259 
(type 4-5) lesions (Fig. 5C). However, also no significant differences were observed in lesion 260 
composition between Px, Sx and sham operated mice, with respect to the relative area of 261 
smooth muscle cells (SMC; α-actin staining; Fig. 5D), collagen (Sirius Red staining; Fig. 5E) and 262 
macrophages (MAC3 staining; Fig. 5F). 263 
264 
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Discussion 265 
In the current study, we tested the hypothesis that the brain plays a prominent role in modulating 266 
the activity of immune cells and may therefore affect atherosclerosis development. We 267 
determined the effect of selective splenic parasympathetic denervation (Px), sympathetic 268 
denervation (Sx) on the inflammatory status and examined the potential consequences for 269 
plasma lipids and the development of atherosclerosis in APOE*3-Leiden.CETP mice. We 270 
showed that predominantly splenic Px increased the inflammatory state of the body as indicated 271 
by increased leukocyte counts within the spleen and increased pro-inflammatory cytokine 272 
expression. However, splenic Px as well as Sx did not affect atherosclerotic lesion development. 273 
Interestingly, we found increased circulating levels of the pro-inflammatory cytokines IL-274 
1β and IL-6 upon both Px and Sx. Classically, the parasympathetic and sympathetic nerves 275 
system act in opposite direction to facilitate control over physiological responses to maintain 276 
homeostasis. However, for the spleen, it has been suggested that both systems in fact act 277 
together to restrain inflammation by projection of the vagus nerve also onto the sympathetic 278 
splenic nerve (18; 23). Previous studies even suggested absence of direct parasympathetic 279 
innervation of the spleen as neither choline acetyltransferase nor vesicular acetylcholine 280 
transporter producing nerve endings could be detected within the spleen (2; 18). However the 281 
absence of the classical vagus transmitter acetylcholine is not sufficient proof for the absence of 282 
direct input from the vagus. In previous studies we identified neuronal connections between the 283 
spleen and both the intermedio lateral column of the spinal cord (IML) and the dorsal motor 284 
nucleus of the vagus nerve (DMV) by retrograde tracing using pseudorabies virus (PRV) and 285 
cholera toxin-b (CTB) (5; 6), suggesting sympathetic as well as parasympathetic neuronal 286 
connectivity. Surgical ablation of the nerves along the splenic arteries (similar to Sx) resulted in 287 
undetectable retrograde tracer in the IML and absence of TH in the spleen. In contrast, surgical 288 
ablation of the nerve branches at the splenic ends (similar to Px) resulted in a loss of 289 
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detectability of the tracers in the DMV and can therefore most likely be allocated to the 290 
parasympathetic nerves system. In addition, Px severely diminished (-70%) LPS-induced 291 
antibody production, clearly indicating functional involvement of these nerve branches in the 292 
control of the immune response (5). In contrast, Sx did not affect the production of specific 293 
antibodies. While absence of sympathetic input 15 weeks after Sx was confirmed by measuring 294 
TH content, confirmation of Px was limited to visual inspection due to the lack of specific 295 
markers for these neurons. However, consistent with the notion that vagal activation suppresses 296 
the immune response (24), we found that Px enhances the number of leukocytes and increases 297 
expression of pro-inflammatory cytokines. It may seem contradictive that Px results in 298 
diminished LPS-induced antibody production (5), while here we report enhanced inflammatory 299 
responses. However, one should consider the dual challenge for the brain during inflammation, 300 
namely to contain the inflammation by for example reducing cytokine production, and 301 
subsequently to induce memory within the immune system to prevent new infections by inducing 302 
antibody production. 303 
Despite that Px increased the number of immune cells in the spleen in the current study, 304 
no differences in splenic TNFα gene expression or circulating TNFα levels were found. Possibly 305 
stronger inflammatory stimuli are required to attenuate TNFα production by spleen macrophages 306 
via stimulation of the vagus nerve, as has been shown for LPS-induced endotoxemia (18). 307 
Compatible with the notion that TNFα is crucially involved in the pathogenesis and progression 308 
of atherosclerosis (4; 14), Px and Sx did not aggravate WTD-induced atherosclerotic lesion 309 
development and did not affect lesion composition in APOE*3-Leiden.CETP mice. Similarly, we 310 
previously showed that hematopoietic α7nAChR deficiency in ApoE-/- mice does increase 311 
inflammatory status of the body and enhances platelet reactivity, but does not aggravate 312 
atherosclerosis as lesion size and plaque composition remained unaffected (15). In contrast, 313 
Johansson et al. (13) recently reported an increase in atherosclerotic lesion development upon 314 
hematopoietic α7nAChR deficiency in Ldlr-/- mice, indicating that the genetic and environmental 315 
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context are important to determine the outcome of disrupted anti-inflammatory reflexes. Despite 316 
conflicting outcomes, interfering with inflammatory reflexes might be an interesting target in the 317 
prevention of atherosclerosis. Several animal studies report beneficial effects of low dose β-318 
blockers on atherogenesis (20; 21), mainly via reducing of inflammatory responses rather than 319 
changes in lipid metabolism. Also in humans, the use of metoprolol slows progression of intima-320 
media thickness (9; 26). 321 
While the role of the autonomic splenic nerves in human physiology is unclear, 322 
splenectomy in trauma patients has been associated with frequency of ischemic coronary 323 
diseases, probably explained by increased plasma lipids (17). Rodent studies confirmed the role 324 
of the spleen in lipid metabolism as splenectomized rats showed reduced HDL-cholesterol and 325 
increased plasma triglycerides. Complete removal of the spleen in ApoE-deficient mice 326 
increased plaque development, although the underlying mechanism remained elusive (16). In 327 
the current study, no differences in plasma lipids were found upon splenic denervations, 328 
suggesting that regulation of lipid metabolism via the spleen is probably not mediated via 329 
innervation of the splenic nerves, which may explain why atherosclerosis development was not 330 
aggravated in this study. Interestingly, splenectomized trauma patients do display increased 331 
infection rates and have increased leukocyte counts (1), corresponding with the data presented 332 
in the current study, however the exact contribution of an isolated increased inflammatory status 333 
without effects on plasma lipid levels to atherosclerosis development is unclear. 334 
In conclusion, selective disruption of mainly the splenic parasympathetic nerve increases 335 
splenic immune cell counts and the systemic inflammatory status, but does not contribute to 336 
atherosclerotic lesion development. 337 
 338 
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Figure legends 430 
 431 
Figure 1. Confirmation of splenic denervations and gating strategy 432 
Schematic representation of the innervation of the spleen (A). The sympathetic input (pink) 433 
reaches the spleen via the arteries, the parasympathetic input (green) reaches the spleen via 434 
both tips of the spleen. The location at which denervations were performed are shown by the 435 
dashed lines. Gating strategy for flow cytometry analysis (B). Confirmation of sympathetic 436 
denervation  (C) by measurement of tyrosine hydroxylase protein content of the spleen. As 437 
controls, TH content for the brain and (denervated) brown fat are included. 438 
 439 
Figure 2. Effect of splenic denervation on immune cell composition of the spleen. 440 
APOE*3-Leiden.CETP mice were fed a WTD during 4 weeks, were randomized into three 441 
groups receiving either splenic parasympathetic denervation (Px), sympathetic denervation (Sx), 442 
or sham surgery (t=0). Mice were fed a WTD during 15 additional weeks before spleens were 443 
isolated and cellular composition was analyzed by flow cytometry. Immune cells were counted 444 
based on FSC (A) and further subdivided into B cells (CD19+) (B), T cells (CD3+) (C), dendritic 445 
cells (CD11c+CD14-) (D), neutrophils (CD11b+Ly6Ghigh) (E) and monocytes/macrophages 446 
(CD14+CD11b+) (F). Specific T cells subsets were identified as TH (CD4+) (G), TCyt (CD8+) (H), 447 
naïve TH (CD4+CD62L+) (I), activated TH (CD4+ CD25+ (J), naïve TCyt (CD8+CD62L+) (K) and 448 
activated TCyt (CD8+ CD25+ (L). Values represent means ± SEM of 5 mice per group. *p<0.05, 449 
**p<0.01 compared to sham surgery. 450 
 451 
Figure 3. Effect of splenic denervation on the gene expression of inflammatory genes.  452 
During the course of the experiment body weight was monitored (A). At 15 weeks after Px, Sx or 453 
sham surgery, spleens were weighed (B) and splenic weight was expressed as percentage of 454 
body weight (C), total RNA was extracted and expression levels of TNFα, IL-1β and IL-6 were 455 
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determined by real-time PCR (D). Similarly, livers were weighed (E) and hepatic expression of 456 
these genes was determined (F). Peritoneal leukocytes were isolated and gene expression was 457 
quantified (G). Values represent means ± SEM of 15 mice per group *p<0.05, **p<0.01, 458 
***p<0.01  compared to sham surgery. 459 
 460 
Figure 4. Effect of splenic denervation on white blood cell composition, serum cytokines 461 
and plasma lipids. 462 
At 15 weeks after Px, Sx or sham surgery, blood was drawn and analyzed by flow cytometry. 463 
Immune cells were counted (A) and further subdivided into B cells (CD19+) (B), T cells (CD3+) 464 
(C), dendritic cells (CD11c+CD14-) (D), neutrophils (CD11b+Ly6Ghigh) (E) and monocytes 465 
(CD14+CD11b+) (F). Serum cytokine levels of TNFα (G), IL-1β (H) and IL-6 (I) were measured. 466 
Plasma concentrations of total cholesterol (TC), phospholipids (PL) and triglycerides (TG) were 467 
determined (J). The distribution of cholesterol over the different lipoproteins was determined by 468 
fractionation of pooled plasma by FPLC (K). Serum E-selectin (L). Values represent means ± 469 
SEM of 5 (A-F) or 15 (G-L) mice per group. 470 
 471 
Figure 5. Effect of splenic denervation on atherosclerotic lesion size and composition. 472 
At 15 weeks after Px, Sx or sham surgery, hearts were isolated and cross-sections (5 μm) with 473 
50 μm intervals throughout the aortic root area starting from the appearance of open aortic valve 474 
leaflets were used for atherosclerosis measurements. Sections were stained with hematoxylin-475 
phloxine-saffron for histological analysis and representative images are shown (A). 476 
Atherosclerotic mean lesion area (in µm2) was quantified in four subsequent cross-sections (B). 477 
The same four sections per mouse were categorized according to lesion severity (C). Lesion 478 
composition was determined by immunohistochemistry in four subsequent cross-sections using 479 
α-actin for smooth muscle cells (SMC) (D), Sirius Red staining for collagen content (E) and 480 
MAC3 for macrophages (F). Values represent means ± SEM of 15 mice per group. 481 
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Table 1: Detailed information of antibodies used for flow cytometry analysis. 482 
 483 
Antibody Conjugate Clone Source Dilution
CD19 PE ID3 BD 1,600
CD14 FITC Sa14-2 eBioscience 500
CD11c Biotin HL3 BD 200
CD3 APC 145-2C11 BD 300
CD3 FITC 145-2C11 BD 400
CD11b PerCP M1/70 BD 800
Ly6G Ef450 RB6-8C5 eBioscience 800
CD4 PE L3T4 GK1.5 BD 1,000
CD8 biotin 53-6.7 BD 400
CD62L APC MEL-14 Biolegend 1,600
CD25 PerCP PC61 BD 500
Second step: Sav-PE-Cy7 BD 500
 484 
 485 
 486 
 487 
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